The Mito Foundation's purpose is to end suffering from mitochondrial disease (mito). To reach that goal, we are working towards preventions, treatments and cures for mito. We are also working to make these easily accessible to people with mito.
Our Research and Medical Grant Program drives research into mito. We do this by identifying and funding impactful research and clinical work. Today, Mito Foundation is the second largest philanthropic funder of mito research worldwide. We have funded over 100 research grants.
Since 2010, we have supported researchers to make significant progress in mito research. Together, we are already improving the lives of people impacted by mito. Help us continue this important work by donating today.
to mito research worldwide.
Research highlights from 2023
Across 6 projects, every $1 we invested led to a further $5.3 in external funding
6 research studies were made available to the Australian mito community
Identified a new mito gene, CRLS1
Pre-clinical testing of a gene editing technology to treat mito
Research priority areas
We're committed to achieving the greatest impact for the mito community. To do this, we aim to fund the world's best mito research across 4 priority areas.
Understanding the molecular and cellular processes involved in mito is essential. This is the foundation for much of mito research.
Since 2010, Mito Foundation has funded over 40 grants in this area of research. Discoveries from these projects are leading to advancements in:
- prevention, treatments and cures.
"Early diagnosis has saved him from numerous related health conditions and possible death at an early age."
We regularly support researchers, and their teams, over many years, through multiple grants. This develops expertise and a stronger mito workforce. It also enables researchers to build on their discoveries. Over time, these research journeys have a great impact on the field of mito research and the mito community.
Associate Professor David Stroud's work pioneering a new diagnostic technique
Quantitative proteomics is a tool that has the potential to drastically improve mito diagnostic rates from around 50% toward 70%. Proteomics can be used to diagnose people who are still living without a diagnosis after traditional methods failed to provide an answer.
We've funded over
Our research investments
We've funded over 100 projects across our 4 research priority areas. Below is a summary of our research investment across these areas during 2010 – 2023.